- $4.63bn
- $4.22bn
- $390.40m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 53.13 | ||
| PEG Ratio (f) | 1.14 | ||
| EPS Growth (f) | 87.25% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 12.4 | ||
| Price to Tang. Book | 15.11 | ||
| Price to Free Cashflow | 53 | ||
| Price to Sales | 9.64 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -145.02% | ||
| Return on Equity | -340.01% | ||
| Operating Margin | -114.49% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | 292.73 | 390.4 | 550.56 | 656.76 | 33.37% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +17.01 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- June 30th, 2025
- Incorporated
- March 10th, 2016
- Public Since
- May 22nd, 2025
- No. of Employees
- 1,514
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
New York Stock Exchange- Shares in Issue
- 78,435,247
- Address
- 455 Market Street, Suite 700, SAN FRANCISCO, 94105
- Web
- https://en-gb.hingehealth.com/
- Phone
- +1 4156898429
- Auditors
- Deloitte & Touche LLP
Upcoming Events for HNGE
Similar to HNGE
Agilon Health
New York Stock Exchange
AMERICAN WELL
New York Stock Exchange
AMN Healthcare Services
New York Stock Exchange
Ardent Health
New York Stock Exchange
Auna SA
New York Stock Exchange
FAQ
As of Today at 21:06 UTC, shares in Hinge Health are trading at $59.07. This share price information is delayed by 15 minutes.
Shares in Hinge Health last closed at $59.07 and the price had moved by over the past 365 days. In terms of relative price strength the Hinge Health share price has matched the S&P500 Index by over the past year.
The overall consensus recommendation for Hinge Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreHinge Health does not currently pay a dividend.
Hinge Health does not currently pay a dividend.
Hinge Health does not currently pay a dividend.
To buy shares in Hinge Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $59.07, shares in Hinge Health had a market capitalisation of $4.63bn.
Here are the trading details for Hinge Health:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: HNGE
Based on an overall assessment of its quality, value and momentum Hinge Health is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Hinge Health is $60.69. That is 2.74% above the last closing price of $59.07.
Analysts covering Hinge Health currently have a consensus Earnings Per Share (EPS) forecast of $1.01 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hinge Health. Over the past six months, its share price has matched the S&P500 Index by .
As of the last closing price of $59.07, shares in Hinge Health were trading +30.97% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Hinge Health PE ratio based on its reported earnings over the past 12 months is 53.13. The shares last closed at $59.07.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Hinge Health's directors